Literature DB >> 27554814

Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children.

Marie-Louise Frémond1, Mathieu Paul Rodero2, Nadia Jeremiah3, Alexandre Belot4, Eric Jeziorski5, Darragh Duffy6, Didier Bessis7, Guilhem Cros8, Gillian I Rice9, Bruno Charbit10, Anne Hulin11, Nihel Khoudour11, Consuelo Modesto Caballero12, Christine Bodemer13, Monique Fabre14, Laureline Berteloot15, Muriel Le Bourgeois16, Philippe Reix17, Thierry Walzer18, Despina Moshous19, Stéphane Blanche20, Alain Fischer21, Brigitte Bader-Meunier22, Fréderic Rieux-Laucat3, Yanick Joseph Crow23, Bénédicte Neven24.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27554814     DOI: 10.1016/j.jaci.2016.07.015

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  56 in total

Review 1.  Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.

Authors:  Hirotsugu Oda; Daniel L Kastner
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

2.  Mosaic Tetrasomy 9p Associated With Inflammatory Bowel Disease.

Authors:  Luis Sifuentes-Dominguez; Petro Starokadomskyy; Jacob Welch; Bhaskar Gurram; Jason Y Park; Prasad Koduru; Ezra Burstein
Journal:  J Crohns Colitis       Date:  2019-10-28       Impact factor: 9.071

Review 3.  [Familial chilblain lupus : Type 1 interferonopathy with model character].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

Review 4.  Immune Diseases Associated with TREX1 and STING Dysfunction.

Authors:  Nan Yan
Journal:  J Interferon Cytokine Res       Date:  2017-05       Impact factor: 2.607

5.  JAK 1/2 Blockade in MDA5 Gain-of-Function.

Authors:  Kirsty E McLellan; Neil Martin; Joyce E Davidson; Nuno Cordeiro; Bridget D Oates; Bénédicte Neven; Gillian I Rice; Yanick J Crow
Journal:  J Clin Immunol       Date:  2018-11-15       Impact factor: 8.317

6.  Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models.

Authors:  Mona Motwani; Sudesh Pawaria; Jennifer Bernier; Stephanie Moses; Kate Henry; Terry Fang; Linda Burkly; Ann Marshak-Rothstein; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-03       Impact factor: 11.205

Review 7.  Familial Chilblain Lupus - What Can We Learn from Type I Interferonopathies?

Authors:  Christoph Fiehn
Journal:  Curr Rheumatol Rep       Date:  2017-08-26       Impact factor: 4.592

Review 8.  Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review.

Authors:  Yvan Jamilloux; Alexandre Belot; Flora Magnotti; Sarah Benezech; Mathieu Gerfaud-Valentin; Emilie Bourdonnay; Thierry Walzer; Pascal Sève; Thomas Henry
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 9.  JAK inhibitors in dermatology: The promise of a new drug class.

Authors:  William Damsky; Brett A King
Journal:  J Am Acad Dermatol       Date:  2017-01-28       Impact factor: 11.527

10.  Genetic, Phenotypic, and Interferon Biomarker Status in ADAR1-Related Neurological Disease.

Authors:  Gillian I Rice; Naoki Kitabayashi; Magalie Barth; Tracy A Briggs; Annabel C E Burton; Maria Luisa Carpanelli; Alfredo M Cerisola; Cindy Colson; Russell C Dale; Federica Rachele Danti; Niklas Darin; Begoña De Azua; Valentina De Giorgis; Christian G L De Goede; Isabelle Desguerre; Corinne De Laet; Atieh Eslahi; Michael C Fahey; Penny Fallon; Alex Fay; Elisa Fazzi; Mark P Gorman; Nirmala Rani Gowrinathan; Marie Hully; Manju A Kurian; Nicolas Leboucq; Jean-Pierre S-M Lin; Matthew A Lines; Soe S Mar; Reza Maroofian; Laura Martí-Sanchez; Gary McCullagh; Majid Mojarrad; Vinodh Narayanan; Simona Orcesi; Juan Dario Ortigoza-Escobar; Belén Pérez-Dueñas; Florence Petit; Keri M Ramsey; Magnhild Rasmussen; François Rivier; Pilar Rodríguez-Pombo; Agathe Roubertie; Tommy I Stödberg; Mehran Beiraghi Toosi; Annick Toutain; Florence Uettwiller; Nicole Ulrick; Adeline Vanderver; Amy Waldman; John H Livingston; Yanick J Crow
Journal:  Neuropediatrics       Date:  2017-04-10       Impact factor: 1.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.